| |
 |
|
Class Information
Number: 424/234.1
Name: Drug, bio-affecting and body treating compositions > Antigen, epitope, or other immunospecific immunoeffector (e.g., immunospecific vaccine, immunospecific stimulator of cell-mediated immunity, immunospecific tolerogen, immunospecific immunosuppressor, etc.) > Bacterium or component thereof or substance produced by said bacterium (e.g., legionella, borrelia, anaplasma, shigella, etc.)
Description: Subject matter involving a bacterium, a component of a bacterium, or a substance produced by a bacterium.
Sub-classes under this class:
| Class Number |
Class Name |
Patents |
| 424/246.1 |
Bacillus |
69 |
| 424/253.1 |
Bordetella (e.g., bordetella bronchiseptica, etc.) |
69 |
| 424/252.1 |
Brucella (e.g., brucella abortus, brucella canis, etc.) |
31 |
| 424/263.1 |
Chlamydia (e.g., chlamydia trachomatis, etc.) |
78 |
| 424/247.1 |
Clostridium (e.g., clostridium tetani, clostridium difficile, clostridium perfringens, clostridium botulinum, clostridium chauvoei, etc.) |
98 |
| 424/245.1 |
Corynebacterium (e.g., corynebacterium diphtheriae, etc.) |
47 |
| 424/257.1 |
Escherichia (e.g., escherichia coli, etc.) |
150 |
| 424/256.1 |
Hemophilus (e.g., hemophilus influenzae, hemophilus gallinarum, hemophilus pleuropnemoniae, etc.) |
196 |
| 424/259.1 |
Klebsiella (e.g., klebsiella pneumoniae, etc.) |
30 |
| 424/251.1 |
Moraxella (e.g., moraxella bovis, etc.) |
55 |
| 424/248.1 |
Mycobacterium (e.g., mycobacterium tuberculosis, calmette-guerin bacillus (i.e., bcg), etc.) |
233 |
| 424/264.1 |
Mycoplasma |
46 |
| 424/249.1 |
Neisseria (e.g., neisseria gonorrhoeae, etc.) |
93 |
| 424/255.1 |
Pasteurella (e.g., pasteurella multocida, pasteurella hemolytica, etc.) |
88 |
| 424/242.1 |
Pilus, fimbria, or adhesin |
81 |
| 424/260.1 |
Pseudomonas (e.g., pseudomonas aeruginosa, etc.) |
90 |
| 424/258.1 |
Salmonella (e.g., salmonella typhimurium, etc.) |
142 |
| 424/243.1 |
Staphylococcus (e.g., staphylococcus aureus, etc.) |
107 |
| 424/244.1 |
Streptococcus (e.g., group b streptococcus, pneumococcus or streptococcus pneumoniae, etc.) |
300 |
| 424/236.1 |
Toxin or toxoid, except endotoxin (e.g., exotoxin, enterotoxin, etc.) |
329 |
| 424/235.1 |
Transposon mutant or deletion mutant bacterium (e.g., produced by transposon mutagenesis, etc.) |
94 |
| 424/262.1 |
Treponema (e.g., treponema hyodysenteriae, treponema pallidum, etc.) |
42 |
| 424/261.1 |
Vibrio (e.g., vibrio cholera, etc.) |
82 |
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 5531989 |
Immunoglobulin and fiber-containing composition for human gastrointestinal health |
Jul. 2, 1996 |
| 5529924 |
Legionella specific antibiotic produced by Streptomyces sp AL91 access ion number KCCM 10055 |
Jun. 25, 1996 |
| 5530103 |
Method for the purification of PC protein from Borrelia burgdorferi |
Jun. 25, 1996 |
| 5523089 |
Borrelia antigen |
Jun. 4, 1996 |
| 5512282 |
Monospecific polyclonal antibodies to shiga-like toxins |
Apr. 30, 1996 |
| 5503829 |
Recombinant mutants for inducing specific immune responses |
Apr. 2, 1996 |
| 5503997 |
A process for producing legionella specific antibiotic using Streptomyces sp. AL91 |
Apr. 2, 1996 |
| 5498414 |
Attenuated strains of Aeromonas salmonicida useful as fish vaccines |
Mar. 12, 1996 |
| 5494673 |
Phosphazene polyelectrolytes as immunoadjuvants |
Feb. 27, 1996 |
| 5486630 |
Legionella specific antibiotic |
Jan. 23, 1996 |
| 5478559 |
Method and composition for increasing body weight and stimulating immune systems |
Dec. 26, 1995 |
| 5470573 |
Immunogens comprising the non-lytic membrane spanning domain of bacteriophages MS2 or PhiX174 |
Nov. 28, 1995 |
| 5456914 |
Transthoracic intrapulmonary immunization against Actinobacillus pleuropneumoniae |
Oct. 10, 1995 |
| 5445820 |
Streptolysin O peptide antigens and methods for the determination of streptolysin antibodies |
Aug. 29, 1995 |
| 5443832 |
Hydroxyapatite-antigen conjugates and methods for generating a poly-Ig immune response |
Aug. 22, 1995 |
| 5441737 |
Use of apotransferrin that has bound zinc or copper ions for treatment of toxic effects of endotoxins |
Aug. 15, 1995 |
| 5439810 |
Manipulation of gene copy number in bordetella |
Aug. 8, 1995 |
| 5436000 |
Flagella-less borrelia |
Jul. 25, 1995 |
| 5434077 |
Borrelia burgdorferi strain 257 |
Jul. 18, 1995 |
| 5422110 |
Enhanced immunogenicity using leukotoxin chimeras |
Jun. 6, 1995 |
| 5417971 |
Vaccines for Actinobacillus pleuropneumoniae |
May. 23, 1995 |
| 5382428 |
Method for preparing a purified extraction residue fraction and its use in stimulating the immune response |
Jan. 17, 1995 |
| 5374423 |
Method of using cytokine receptors on microorganism |
Dec. 20, 1994 |
| 5352448 |
Oral administration of antigens |
Oct. 4, 1994 |
| 5332572 |
Method for protection of swine against pleuropneumonia |
Jul. 26, 1994 |
| 5292869 |
Method for isolating and purifying transferrin and lactoferrin receptor proteins from bacteria and the preparation of vaccines containing the same |
Mar. 8, 1994 |
| 5270038 |
Tumor necrosis factor receptors on microorganisms |
Dec. 14, 1993 |
| 5225194 |
Aqueous diafiltration process for preparing acellular vaccines, against selected bacterial diseases |
Jul. 6, 1993 |
| 5210035 |
Non-reventing live vaccines |
May. 11, 1993 |
| 5204097 |
Shiga toxin B chain polypeptides and vaccine thereto |
Apr. 20, 1993 |
| 5202119 |
Method of stimulating immune response |
Apr. 13, 1993 |
| 5200179 |
Vaccine |
Apr. 6, 1993 |
| 5189028 |
Composition and method to enhance the efficacy of a fish vaccine and to stimulate the immune system of fish |
Feb. 23, 1993 |
| 5182109 |
Vaccine preparation comprising a bacterial toxin adjuvant |
Jan. 26, 1993 |
| 5178859 |
Vaccine against Lyme disease |
Jan. 12, 1993 |
| 5141743 |
Method for isolating and purifying transferrin and lactoferrin receptor proteins and vaccines containing the same |
Aug. 25, 1992 |
| 5108745 |
Tuberculosis and legionellosis vaccines and methods for their production |
Apr. 28, 1992 |
| 5084269 |
Adjuvant for dose treatment with antigens |
Jan. 28, 1992 |
| 5077044 |
Novel non-reverting shigella live vaccines |
Dec. 31, 1991 |
| 5045456 |
Process for removing bacterial endotoxin from gram-negative polysaccharides |
Sep. 3, 1991 |
| 5039610 |
Process for removing bacterial endotoxin from gram-negative polysaccharides |
Aug. 13, 1991 |
| 5019384 |
Immunonodulating compositions and their use |
May. 28, 1991 |
| 5019502 |
Process for removing bacterial endotoxin from gram-negative polysaccharides |
May. 28, 1991 |
| 5006463 |
Immunoassays for discriminating between brucellosis infections and vaccinations |
Apr. 9, 1991 |
| 4981685 |
Bacterial extract vaccines for veterinary application |
Jan. 1, 1991 |
| RE33403 |
Method for treating disorders of the vascular and pulmonary systems |
Oct. 23, 1990 |
| 4911918 |
Oral composition containing stabilized antibody |
Mar. 27, 1990 |
| 4880626 |
Immunotherapeutic methods and compositions for the treatment of diseases of viral origin, including acquired immune deficiency syndrome |
Nov. 14, 1989 |
| 4877613 |
Process for preparing veterinary acellular vaccines against gram-negative nonenteric pathogenic bacilli |
Oct. 31, 1989 |
| 4806352 |
Immunological lipid emulsion adjuvant |
Feb. 21, 1989 |
|
|
|
